The B cell receptor signaling pathway in mantle cell lymphoma.

about

The B cell receptor signaling pathway in mantle cell lymphoma.

Item

http://www.wikidata.org/entity/Q54977238

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

The B cell receptor signaling pathway in mantle cell lymphoma.

@en

The B cell receptor signaling pathway in mantle cell lymphoma.

@nl

type

Item

label

The B cell receptor signaling pathway in mantle cell lymphoma.

@en

The B cell receptor signaling pathway in mantle cell lymphoma.

@nl

prefLabel

The B cell receptor signaling pathway in mantle cell lymphoma.

@en

The B cell receptor signaling pathway in mantle cell lymphoma.

@nl

P1476

The B cell receptor signaling pathway in mantle cell lymphoma.

@en

P2093

Krystle Nomie

http://www.w3.org/2001/XMLSchema#string

Makhdum Ahmed

http://www.w3.org/2001/XMLSchema#string

Maria I Merolle

http://www.w3.org/2001/XMLSchema#string

Michael L Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Phosphorylation of the CARMA1 linker controls NF-kappaB activation

Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia

Expression of dominant-negative src-homology domain 2-containing protein tyrosine phosphatase-1 results in increased Syk tyrosine kinase activity and B cell activation

Regulation of Btk function by a major autophosphorylation site within the SH3 domain

Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells

Amplification of B cell antigen receptor signaling by a Syk/ITAM positive feedback loop

Immunodeficiency in protein kinase cbeta-deficient mice

TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB

Postibrutinib outcomes in patients with mantle cell lymphoma.

Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma

P304

25332-25341

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.25011

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29861875

http://www.w3.org/2001/XMLSchema#string

P932

5982769

http://www.w3.org/2001/XMLSchema#string